🔎 Trials Near Me

Home › Non-Small Cell Lung Cancer › New York › Albany

Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Albany, NY

9 pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Albany (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

Nagre-recruitPhase 3
  • New York Oncology Hematology, P.C. ( Site 0132), Albany
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06345729

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

Nagre-recruitPhase 3
  • New York Oncology Hematology, P.C. ( Site 0119), Albany
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07190248

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

Nagre-recruitPhase 3
  • New York Oncology Hematology, P.C. ( Site 9000), Albany
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07513376

A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

Nagre-recruitPhase 3
  • New York Oncology Hematology P.C ( Site 9000), Albany
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07554339

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Nagre-recruitPhase 3
  • New York Oncology Hematology, Albany
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07222566

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Nagre-recruitPhase 2/3
  • New York Oncology Hematology - Albany Medical Center, Albany
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT04613596

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

Nagre-recruitPhase 2
  • ONE Onc: New York Oncology Hematology, Albany
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT07288177

MYLUNG Consortium Part 3: Observational Study

Nagre-recruitObservasyonal na pag-aaral
  • New York Oncology Hematology, P.C., Albany
Edad 18 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT05885698

GEMINI-NSCLC: NSCLC Biomarker Study

Nagre-recruitObservasyonal na pag-aaral
  • New York Oncology Hematology, Albany
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 5, 2026 · NCT05236114

Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa Albany

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.